Leukocyte depletion for leukaemia and multiple sclerosis.
作者信息
Bonn D
出版信息
Mol Med Today. 1998 Dec;4(12):508.
PMID:9866817
Abstract
摘要
相似文献
1
Leukocyte depletion for leukaemia and multiple sclerosis.用于白血病和多发性硬化症的白细胞去除术。
Mol Med Today. 1998 Dec;4(12):508.
2
Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.慢性淋巴细胞白血病。当前治疗策略与新展望
Haematologica. 1999 Jun;84 Suppl EHA-4:94-5.
3
Alemtuzumab (Millennium/ILEX).阿仑单抗（千年制药公司/ILEX公司）。
Curr Opin Investig Drugs. 2001 Jan;2(1):139-60.
4
Advances in the use of alemtuzumab in CLL.阿仑单抗在慢性淋巴细胞白血病治疗中的应用进展。
Clin Adv Hematol Oncol. 2008 Jan;6(1):23-4.
5
[Evidence-based therapy for chronic leukemia].[慢性白血病的循证治疗]
Nihon Naika Gakkai Zasshi. 2003 Jun 10;92(6):979-85.
6
Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
Br J Haematol. 2008 Jul;142(1):1. doi: 10.1111/j.1365-2141.2007.06970.x. Epub 2008 May 8.
7
Alemtuzumab in chronic lymphocytic leukemia.阿仑单抗治疗慢性淋巴细胞白血病
Future Oncol. 2007 Feb;3(1):29-42. doi: 10.2217/14796694.3.1.29.
8
NCCN: New directions in chronic lymphocytic leukemia.美国国立综合癌症网络（NCCN）：慢性淋巴细胞白血病的新方向
Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):114-7.
9
[A new therapeutic alternative in chronic B-lymphocytic leukemia].
Rev Infirm. 2002 Dec(86):38-40.
10
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
J Clin Oncol. 2008 Nov 10;26(32):5299-301. doi: 10.1200/JCO.2008.18.6270. Epub 2008 Oct 14.
Zotero 插件